Skip to main content
. 2018 Oct;15(10):628–633. doi: 10.11909/j.issn.1671-5411.2018.10.008

Table 1. Baseline characteristics of the study population.

Variables Total (n = 322) AF (n = 79) No AF (n = 243) P
Male 166 42 (53.1%) 124 (51.0%) 0.79
Age 70.8 ± 5.5 74.7 ± 5.7 69.6 ± 4.8 0.00
SSS 185 50 (63.3%) 135 (55.6%) 0.24
cAVB 75 22 (27.8%) 53 (21.8%) 0.29
Heart failure* 40 12 (15.2%) 28 (11.5%) 0.43
Hypertension 175 71 (89.9%) 104 (42.8%) 0.00
Diabetes 83 19 (24.1%) 64 (26.3%) 0.77
Ischemic stroke/TIA 47 12 (15.2%) 35 (14.4%) 0.86
Vascular diseaseΔ 37 12 (15.2%) 25 (10.3%) 0.23
LAD, mm 37.6 ± 3.8 41.7 ± 2.9 36.3 ± 3.0 0.00
LVEDD, mm 50.1 ± 4.9 50.3 ± 5.4 49.4 ± 4.8 0.24
LVEF% 56.3 ± 5.4 55.5 ± 4.9 56.6 ± 5.4 0.31
AP% 40.0 ± 16.4 45.0 ± 15.6 38.3 ± 16.3 0.01
VP% 48.7 ± 17.1 54.9±12.8 46.5 ± 17.8 0.00
CHA2DS2-VASc score 3.74 ± 1.42 3.27 ± 1.58 2.56 ± 1.32 0.00

Data are presented as means ± SD or n (%). *Patient had been diagnosed with heart failure and maintained treatment when cardiac function during the perioperative period was grade I (New York Hospital Association classification); ΔOld myocardial infarction or peripheral vascular disease. AP%: atrial pacing percentage; cAVB: complete atrioventricular block; LAD: left atrial diameter; LVEDD: left ventricular enddiastolic dimension; LVEF: left ventricular ejection fraction; SSS: sick sinus syndrome; TIA: transient ischemic attack; VP%: ventricular pacing percentage.